chr17-63601175-AC-A
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_016360.4(TACO1):βc.97delβ(p.Arg33GlyfsTer54) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000317 in 1,547,066 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β ).
Frequency
Genomes: π 0.000026 ( 0 hom., cov: 32)
Exomes π: 0.000032 ( 0 hom. )
Consequence
TACO1
NM_016360.4 frameshift
NM_016360.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.123
Genes affected
TACO1 (HGNC:24316): (translational activator of cytochrome c oxidase I) This gene encodes a mitochondrial protein that function as a translational activator of mitochondrially-encoded cytochrome c oxidase 1. Mutations in this gene are associated with Leigh syndrome.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 5 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-63601175-AC-A is Pathogenic according to our data. Variant chr17-63601175-AC-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 818073.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TACO1 | NM_016360.4 | c.97del | p.Arg33GlyfsTer54 | frameshift_variant | 1/5 | ENST00000258975.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TACO1 | ENST00000258975.7 | c.97del | p.Arg33GlyfsTer54 | frameshift_variant | 1/5 | 1 | NM_016360.4 | P3 | |
TACO1 | ENST00000684587.1 | c.97del | p.Arg33GlyfsTer54 | frameshift_variant | 1/5 | A1 | |||
TACO1 | ENST00000581120.1 | n.299del | non_coding_transcript_exon_variant | 1/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000265 AC: 4AN: 151046Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
151046
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000684 AC: 1AN: 146110Hom.: 0 AF XY: 0.0000126 AC XY: 1AN XY: 79408
GnomAD3 exomes
AF:
AC:
1
AN:
146110
Hom.:
AF XY:
AC XY:
1
AN XY:
79408
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000322 AC: 45AN: 1396020Hom.: 0 Cov.: 31 AF XY: 0.0000291 AC XY: 20AN XY: 688404
GnomAD4 exome
AF:
AC:
45
AN:
1396020
Hom.:
Cov.:
31
AF XY:
AC XY:
20
AN XY:
688404
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000265 AC: 4AN: 151046Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73738
GnomAD4 genome
AF:
AC:
4
AN:
151046
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
73738
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 15, 2022 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at